- Hodgkin Lymphoma
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Meet The Professor Sessions
- Chronic Myeloid Leukemia
- Myeloproliferative Neoplasms
- Breakfast With The Expert
- Independent Satellite Symposium
- Plenary Sessions
- Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
- Acute Lymphoblastic Leukemia
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Indolent B-cell Lymphoma
- Mantle Cell Lymphoma
- Aggressive B-cell Lymphoma
- T-cell Lymphoma
- Cellular Therapy
- Next Questions
- Events
Playback speed
10 seconds
Phase 2 HORIZON Study of Melflufen in Relapsed/Refractory Multiple Myeloma Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety
202 views
November 18, 2019
Comments 0
Login to view comments.
Click here to Login
Multiple Myeloma